Screening blood donations for viral genomes:: multicenter study of real-time simulation using pooled samples on the model of hepatitis C virus RNA detection

被引:16
作者
Lefrère, JJ
Coste, J
Defer, C
Mercier, B
Férec, C
Loiseau, P
Portelette, E
Mariotti, M
Lerable, J
Rouger, P
Pawlotsky, JM
机构
[1] Inst Natl Transfus Sanguine, F-75012 Paris, France
[2] Assistance Publ Hop Paris, Etab Transfus Sanguine, Paris, France
[3] Etab Transfus Sanguine, Montpellier, France
[4] Etab Transfus Sanguine, Lille, France
[5] Etab Transfus Sanguine, Brest, France
[6] Univ Paris 12, Hop Henri Mondor, Lab Bacteriol Virol, F-94010 Creteil, France
关键词
D O I
10.1046/j.1537-2995.1998.381098440855.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
BACKGROUND: The systematic screening for several blood-borne viral genomes in blood donations is a complementary safety measure planned or discussed by the national authorities of several countries. STUDY DESIGN AND METHODS: To appreciate the feasibility of such screening using pooled samples, a multicenter study of real-time simulation has been performed on the model of hepatitis C virus (HCV) infection. Four blood transfusion center laboratories and two research and diagnosis laboratories simultaneously screened, by several HCV RNA polymerase chain reaction assays, a panel of plasma sample posts of different sizes (500, 100, and 10 samples), collected from HCV-infected or HCV-uninfected blood donors. One viremic plasma was introduced in each pool. HCV RNA was detected by in-house polymerase chain reaction procedures or by standardized manual or semi-automated polymerase chain reaction assays. RESULTS: The results indicate the feasibility of sample pooling, which renders the screening for viral genomes by molecular biology techniques applicable in the short term and the importance of the experience of laboratory personnel in the use of molecular biology tools. CONCLUSION: The improvement of standardized assays needs to be continued, and training of laboratory staff members appears to be a crucial step before systematic screening of blood donations for viral genomes by molecular biology techniques can occur.
引用
收藏
页码:915 / 923
页数:9
相关论文
共 14 条
  • [1] BOUCHARDEAU F, 1994, J VIROL METHODS, V49, P79
  • [2] International collaborative study on the second EUROHEP HCV-RNA reference panel
    Damen, M
    Cuypers, HTM
    Zaaijer, HL
    Reesink, HW
    Schaasberg, WP
    Gerlich, WH
    Niesters, HGM
    Lelie, PN
    [J]. JOURNAL OF VIROLOGICAL METHODS, 1996, 58 (1-2) : 175 - 185
  • [3] Comparison of plasma virus loads among individuals infected with hepatitis C virus (HCV) genotypes 1, 2, and 3 by Quantiplex HCV RNA assay versions 1 and 2, Roche monitor assay, and an in-house limiting dilution method
    Hawkins, A
    Davidson, F
    Simmonds, P
    [J]. JOURNAL OF CLINICAL MICROBIOLOGY, 1997, 35 (01) : 187 - 192
  • [4] Performance of the automated COBAS AMPLICOR(TM) system for the detection of hepatitis C virus RNA
    Kessler, HH
    Dragon, EA
    Pierer, K
    Santner, BI
    Liao, YH
    Stunzner, D
    Stelzl, E
    Marth, E
    [J]. CLINICAL AND DIAGNOSTIC VIROLOGY, 1997, 7 (03): : 139 - 145
  • [5] KOLBERG J, 1994, HEPATITIS C VIRUS NE, P71
  • [6] ERROR CONTRIBUTES TO THE RISK OF TRANSMISSIBLE DISEASE
    LINDEN, JV
    [J]. TRANSFUSION, 1994, 34 (11) : 1016 - 1016
  • [7] What technique should be used for routine detection and quantification of HBV DNA in clinical samples?
    Pawlotsky, JM
    Bastie, A
    Lonjon, I
    Remire, J
    Darthuy, F
    Soussy, CJ
    Dhumeaux, D
    [J]. JOURNAL OF VIROLOGICAL METHODS, 1997, 65 (02) : 245 - 253
  • [8] Report of EPFA/NIBSC Workshop, 'Nucleic Acid Amplification Tests (NAT) for the Detection of Blood-Borne Viruses' held on 31 October 1996 in Amsterdam, the Netherlands
    Rogers, PM
    Saldanha, J
    Allain, JP
    [J]. VOX SANGUINIS, 1997, 72 (04) : 199 - 206
  • [9] The risk of transfusion-transmitted viral infections
    Schreiber, GB
    Busch, MP
    Kleinman, SH
    Korelitz, JJ
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1996, 334 (26) : 1685 - 1690
  • [10] STUYVER L, 1994, HEPATITIS C VIRUS NE, P39